(Press-News.org) Compared with people without opioid use disorder, those with opioid use disorder were less likely to receive palliative care in clinics and in their homes, and were dying at younger ages of causes other than opioid use, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231419.
“The majority of conversations about the opioid crisis focus on the high number of opioid toxicity deaths. The unfortunate reality is that people with opioid use disorder are dying young from other causes as well,” says author Dr. Jenny Lau, medical director of the Harold and Shirley Lederman Palliative Care Centre at Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario. “If we can improve our understanding of this population and the health care that they receive at the end of their lives, we can identify opportunities to intervene and improve their quality of life.”
With the ongoing opioid crisis, the number of people with opioid use disorder is increasing. Opioid use disorder can be a chronic, life-limiting illness causing substantial impairment and distress. As the population with opioid use disorder ages, more people will need access to palliative care at the end of their lives. This study describes the characteristics of people with opioid use disorder at the end of their lives and examines whether they receive palliative care.
In this large study that included information from ICES on 679 840 deaths, 11 200 of the deceased (1.6%) had opioid use disorder. People with opioid use disorder died at younger ages than those without opioid use disorder (50 yr v. 78 yr) and were more likely to live in marginalized neighbourhoods. Compared with people without opioid use disorder, people with opioid use disorder were 16% less likely to receive palliative care. This finding is most likely related to the high number of people with opioid use disorder who die suddenly from drug poisonings. The most common reasons why physicians provided palliative care for people with opioid use disorder were cancer, liver cirrhosis, and sepsis.
“Although most people in Canada want to die at home, people with opioid use disorder can have limited social supports, limited finances and unstable housing, which may lead to challenges accessing palliative care in the community and challenges for health care providers to deliver this care,” says coauthor Dr. Sarina Isenberg, chair in mixed methods palliative care research at Bruyère Research Institute, and adjunct scientist, ICES, Ottawa, Ontario. “Our findings highlight the importance of health care providers receiving training in both palliative care and addictions medicine to better support patients with opioid use disorder as they near the end of life.”
END
People with opioid use disorder less likely to receive palliative care at end of life
2024-04-29
ELSE PRESS RELEASES FROM THIS DATE:
New Durham University study reveals mystery of decaying exoplanet orbits
2024-04-29
-With images-
A new study led by researchers at Durham University has uncovered a novel mechanism that could solve a long-standing mystery about decaying planetary orbits around stars like our Sun.
The study, published in The Astrophysical Journal Letters, proposes that stellar magnetic fields play a crucial role in dissipating the gravitational tides responsible for the orbital decay of ‘hot Jupiter’ exoplanets.
Hot Jupiters are massive, gaseous planets similar to Jupiter that orbit extraordinarily close to their parent stars, taking only a few days to complete ...
The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed
2024-04-29
Consistently high vaccination rates and global health surveillance programmes have helped eliminate poliomyelitis (polio) in almost all countries of the world, except Afghanistan and Pakistan. Yet non-polio enteroviruses can also lead to the same devastating symptoms of ‘acute flaccid paralysis’ (AFP), but the world is lacking formal surveillance systems to trace and control these viruses with paralytic potential.
In a presentation at this year’s ESCMID Global Congress (formerly ECCMID) (Barcelona 27-30 April), Prof Thea Kølsen Fischer, Nordsjællands Hospital & University of Copenhagen, Denmark will highlight the continuous dangers that ...
Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses
2024-04-29
With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support complex diagnostic and treatment processes.
Now a new study, being presented at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April), which pitted ChatGPT against the ESCMID guideline for the management of brain abscesses, found that while ChatGPT seems able to give recommendations on key questions about diagnosis and treatment in most cases, some of the AI model’s ...
Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption
2024-04-29
**Note: the release below is from the ESCMID Global Congress (formerly ECCMID, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
New research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found substantial levels of resistance to critically important antibiotics in meat sold for human and animal consumption. The study is by Dr Jordan Sealey, Professor Matthew Avison and colleagues from the University of Bristol, UK.
Meat sold for consumption by humans and companion animals in the UK is regulated by the UK Government Food Standards Agency (FSA) to ensure it falls within bacterial limits deemed ...
Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage
2024-04-28
With the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence (mostly caused by HPV) and mortality by 30% by 2030, meaning each country has a target of vaccinating 90% of girls by age 15, 70% of women receiving a high precision screening test at least at age 35 and 45 years of age, and 90% of all women requiring treatment at any age to receive it. The targets are aspirational and as yet, it appears no country has been ...
Negativity about vaccines surged on Twitter after COVID-19 jabs become available
2024-04-28
It’s time to take a new approach to addressing negative messaging about vaccines, including avoiding the use of the term “anti-vaxxers”, say the researchers.
**ECCMID has now changed name to ESCMID Global, please credit ESCMID Global Congress in all future stories**
There was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became available, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.
The analysis also found that spikes in the number of negative tweets coincided with announcements ...
Global measles cases almost double in a year
2024-04-28
Provisional global total of 321,582 cases for 2023 is almost double (88% higher) than 2022 figure of 171,153
**ECCMID has now changed name to ESCMID Global, please credit ESCMID Global Congress in all future stories**
Measles outbreaks are still occurring and in some cases increasing, among a wide variety of countries, raising concerns of an acceleration similar to just before the COVID pandemic. Dr Patrick O’Connor, of WHO Headquarters, Geneva, Switzerland will give an overview of the global measles situation at this year’s ...
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
2024-04-27
WHAT:
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to findings presented today at the European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona. The results suggest that antibody responses contributed to the effectiveness of dose-sparing mpox vaccine regimens used during the 2022 U.S. outbreak.
The ...
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds
2024-04-27
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.
Post-infection IBS (PI-IBS) is a form of irritable bowel syndrome that occurs after gastroenteritis or food poisoning.
Lead researcher Professor Maurizio Sanguinetti, of the Università Cattolica del Sacro Cuore, Rome, Italy, says: “Estimates vary, but research ...
Experts developing immune-enhancing therapies to target tuberculosis
2024-04-27
Some immune-enhancing therapies already exist, and their use could be investigated while other immunomodulatory drugs specific to different sub-groups of TB disease are being developed
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. In a presentation at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona (27-30 April), Associate Professor Susanna Brighenti, Center for Infectious Medicine (CIM), ANA Futura at the Karolinska ...